Supreme Court Hears Arguments in Case that Threatens Access to Mifepristone

FOR IMMEDIATE RELEASE: March 26, 2024Contact: naf@berlinrosen.com Statement from Brittany Fonteno, President & CEO of the National Abortion Federation on today’s arguments at the U.S. Supreme Court: Access to safe, effective medication abortion care is essential to ensuring people can make decisions about their bodies and lives based on what’s best for their individual circumstances. This case…

Read More

New FDA label for medical abortion pill, Mifeprex

Statement by Vicki Saporta, President and CEO of the National Abortion Federation (NAF), on the New FDA Label for Medical Abortion Pill, Mifeprex: We are delighted that the FDA has approved a label change, which brings the label for mifepristone in-line with scientific research and evidence-based practice. Since mifepristone was initially approved by the FDA…

Read More

Health Canada approves medical abortion medication

FOR IMMEDIATE RELEASE Wednesday, July 29, 2015 CONTACT: Alissa Manzoeillo 202.667.5881, ext 219; 202.595.4395 (after hours/cell) amanzoeillo@prochoice.org   Statement of Vicki Saporta, President and CEO of the National Abortion Federation (NAF) and NAF Canada: The approval of mifepristone is great news for women in Canada. Mifepristone has been safely and effectively used by millions of…

Read More

No Medical Reason for Requiring Ultrasound

Today, the Indianapolis Star, posted my letter to the editor on the state’s anti-choice legislation that would require women to get an ultrasound before a medication abortion.  No matter what supporters of Senate Bill 37 say, this bill is a blatant example of anti-choice legislators attempting to practice medicine without a license. The bill would…

Read More